S&S HEALTHCARE HOLDING LTD. Financials S&S Healthcare Holding Ltd.
Equities
4198
TW0004198007
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.45 TWD | +0.64% |
|
+0.85% | +85.71% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 308 | 157.4 | 551.8 | 502.6 | 546.1 | 616 |
| Enterprise Value (EV) 1 | 261.8 | 217.3 | 597 | 504.7 | 617.7 | 505 |
| P/E ratio | -1.29 x | -1.03 x | -4.51 x | -4.79 x | -7.02 x | 5.69 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.95 x | 0.87 x | 5.44 x | 4.11 x | 2.15 x | 2.24 x |
| EV / Revenue | 0.81 x | 1.2 x | 5.89 x | 4.13 x | 2.43 x | 1.84 x |
| EV / EBITDA | -1.2 x | -1.97 x | -4.82 x | -5.68 x | -7.57 x | -7.03 x |
| EV / FCF | 13.7 x | 10.4 x | -20.4 x | -9.61 x | -3.91 x | -6.35 x |
| FCF Yield | 7.29% | 9.59% | -4.91% | -10.4% | -25.6% | -15.7% |
| Price to Book | 1.28 x | 1.57 x | 8.14 x | 9.14 x | 4.33 x | 2.05 x |
| Nbr of stocks (in thousands) | 8,508 | 8,508 | 13,108 | 16,108 | 20,608 | 24,108 |
| Reference price 2 | 36.20 | 18.50 | 42.10 | 31.20 | 26.50 | 25.55 |
| Announcement Date | 01/04/19 | 30/03/20 | 26/03/21 | 31/03/22 | 29/03/23 | 15/03/24 |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 323.3 | 181.7 | 101.4 | 122.4 | 254.4 | 275.1 |
| EBITDA 1 | -217.6 | -110.5 | -123.7 | -88.93 | -81.63 | -71.88 |
| EBIT 1 | -238.3 | -124.3 | -134.4 | -103.3 | -110.5 | -92.92 |
| Operating Margin | -73.71% | -68.4% | -132.58% | -84.42% | -43.44% | -33.78% |
| Earnings before Tax (EBT) 1 | -237.8 | -152.3 | -114.8 | -95.39 | -70.37 | 102.9 |
| Net income 1 | -238 | -152.4 | -114.9 | -95.39 | -66.88 | 103.6 |
| Net margin | -73.61% | -83.85% | -113.32% | -77.97% | -26.29% | 37.66% |
| EPS 2 | -27.97 | -17.91 | -9.336 | -6.517 | -3.774 | 4.494 |
| Free Cash Flow 1 | 19.09 | 20.82 | -29.3 | -52.51 | -158 | -79.54 |
| FCF margin | 5.91% | 11.46% | -28.91% | -42.91% | -62.1% | -28.91% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 01/04/19 | 30/03/20 | 26/03/21 | 31/03/22 | 29/03/23 | 15/03/24 |
1TWD in Million2TWD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 59.9 | 45.1 | 2.18 | 71.6 | - |
| Net Cash position 1 | 46.1 | - | - | - | - | 111 |
| Leverage (Debt/EBITDA) | - | -0.5416 x | -0.3648 x | -0.0245 x | -0.8769 x | - |
| Free Cash Flow 1 | 19.1 | 20.8 | -29.3 | -52.5 | -158 | -79.5 |
| ROE (net income / shareholders' equity) | -67.4% | -89.5% | -137% | -118% | -44.7% | 33.2% |
| ROA (Net income/ Total Assets) | -23.1% | -19.4% | -28.7% | -22.2% | -16.7% | -10.1% |
| Assets 1 | 1,030 | 786.7 | 400.8 | 430.2 | 399.5 | -1,021 |
| Book Value Per Share 2 | 28.30 | 11.70 | 5.170 | 3.410 | 6.120 | 12.50 |
| Cash Flow per Share 2 | 20.40 | 8.650 | 7.220 | 7.570 | 5.080 | 8.250 |
| Capex 1 | 4.82 | 0.79 | 9.54 | 9.52 | 16.2 | 30.6 |
| Capex / Sales | 1.49% | 0.43% | 9.42% | 7.78% | 6.35% | 11.12% |
| Announcement Date | 01/04/19 | 30/03/20 | 26/03/21 | 31/03/22 | 29/03/23 | 15/03/24 |
1TWD in Million2TWD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +85.71% | 35.28M | |
| +11.29% | 225B | |
| +8.76% | 186B | |
| +12.90% | 135B | |
| +25.95% | 107B | |
| +0.34% | 63.56B | |
| +11.08% | 51.04B | |
| +5.62% | 51.32B | |
| +6.28% | 43.3B | |
| +4.80% | 36.99B |
- Stock Market
- Equities
- 4198 Stock
- Financials S&S Healthcare Holding Ltd.